Showing papers by "David Dranove published in 1995"
Book•
15 Dec 1995
TL;DR: The Origins of Competitive Advantage: Innovation, Evolution, and Environment is followed by the Power of Principles - An Historical Perspective, which examines the role of the environment in the development of strategy.
Abstract: Part 1 Firm boundaries: the evolution of the modern firm the vertical boundaries of the firm the transaction costs of market exchange organizing the vertical chain the horizontal boundaries of the firm diversification Part 2 Market and competitive analysis: industry analysis market structure and competition strategic commitment and competition the dynamic of pricing rivalry entry and exit Part 3 Strategic position and dynamics: strategic positioning for competition advantage analyzing cost and differentiation advantage sustaining competitive advantage the origins of competitive advantage Part 4 Internal organization: incentives and agency strategy and structure power and culture the role of the general manager
262 citations
TL;DR: This article examined two motives for the formation of local multihospital systems: cost reduction and reputation enhancement, and found that local systems do not appear to have lower costs but do appear to enjoy reputation benefits over nonsystem hospitals.
Abstract: This paper examines two motives for the formation of local multihospital systems: cost reduction and reputation enhancement. Systems may reduce costs by eliminating redundancies and reducing administrative costs. Integration may also lower costs for consumers seeking consistently high qualiiy. We hypothesize that if systems achieve either cost or reputation benefits, then member hospitals will ‘look’ different from random collections of hospitals. We find that local systems do not appear to have lower costs but do appear to enjoy reputation benefits over nonsystem hospitals. Our findings challenge the assumptions behind popular health reform initiatives.
146 citations
TL;DR: This paper examined the relationship between basic and applied pharmaceutical research and found that government funding favors diseases that are less prevalent and more debilitating than industry funding, and that research incentives differ across government, academic and industry researchers.
Abstract: This paper examines the relationship between basic and applied pharmaceutical research. We focus on three stages of research and development (R & D): government-funded basic research; publication in medical journals; and industry-finded applied R&D. We estimate that a one percent increase in basic research in a particular therapeutic category causes a 0.76 percent increase in industry R&D in that category, and a 1.71 percent increase in other categories, mer seven years. We also find that research incentives differ across government, academic and industry researchers. For example, government funding favors diseases that are less prevalent and more debilitating than industry funding.
71 citations
TL;DR: Estimates of the surplus loss due to physician practice variation measure the area under the 'shifted' demand curve if the unshifted demand curve is derived form the distribution of true(ex post) values of care.
7 citations